Abstract
BackgroundAlthough tocilizumab (TCZ), an antibody against interleukin-6 receptor, was proved to be effective in reducing signs and symptoms of rheumatoid arthritis (RA) patients in comparatively short time, the information of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
